Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.
Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
In this podcast, Dr Laura Coates of Oxford University discusses the changes made to the guidelines for treatment of psoriatic arthritis by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.
In this podcast, Dr Laura Coates of Oxford University discusses the changes made to the guidelines for treatment of psoriatic arthritis by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.
